Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, B-Cell, Marginal Zone × Everolimus × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Carcinoma, Renal Cell 6 Neuroendocrine Tumors 5 Neoplasm Metastasis 4 Tuberous Sclerosis 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Glioma 2 Diffuse Intrinsic Pontine Glioma 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thymus Neoplasms 1 Skin Neoplasms 1 Seizures 1 Sarcoma 1 Recurrence 1 Pheochromocytoma 1 Phase IB 1 Paraganglioma 1 Ovarian Neoplasms 1 Nevus 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia Type 1 1 Metastatic Digestive System Neuroendocrine Tumor G1 1 Meningioma 1 Lymphoma 1

Interventions

Rituximab 19 Cyclophosphamide 13 Lenalidomide 10 zanubrutinib 8 fludarabine 8 venetoclax 5 fludarabine phosphate 5 pirtobrutinib 4 orelabrutinib 4 Vincristine 4 obinutuzumab 3 Whole-Body Irradiation 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Doxorubicin 3 CT-P10 3 ibrutinib 2 Therapeutics 2 Radiation 2 Mycophenolic Acid 2 Maintenance 2 Leukapheresis 2 Immunotherapy, Adoptive 2 Granulocyte Colony-Stimulating Factor 2 Cyclosporine 2 Biopsy 2 Bendamustine Hydrochloride 2 voruciclib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡